Chapter: 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS
2.2. CXO PERSPECTIVE

Chapter: 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. PORTER'S FIVE FORCES ANALYSIS

3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. TOP PLAYER POSITIONING, 2017
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in geriatric population and favorable demographics
3.5.1.2. Growth in incidence of diabetes, obesity, and chronic conditions
3.5.1.3. Technological advancements to deal with complex wounds
3.5.1.4. Increase in awareness to reduce healthcare costs

3.5.2. Restraints

3.5.2.1. Reluctance in adoption of new technologies
3.5.2.2. Development of substitute products and lack of sufficient evidence

3.5.3. Opportunities

3.5.3.1. Increase in focus towards advanced treatment protocols

3.6. REGULATORY ANALYSIS

3.6.1. Regulatory approval for medical products in the Philippines

3.6.1.1. License To Operate (LTO):
3.6.1.2. Product Registration:

3.6.1.2.1. General Guidelines
3.6.1.2.2. Specific Guidelines
3.6.1.2.3. Legal Requirements for Application for the Notification of Medical Devices under Class A and Registration of Medical Devices under Classes B, C and D

3.7. CLINICAL TRIALS FOR WOUND CARE PRODUCTS

Chapter: 4: PHILIPPINES WOUND CARE MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ADVANCED WOUND CARE

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast

4.2.2.1. Infection management

4.2.2.1.1. Market size and forecast

4.2.2.1.1.1. Silver wound dressings

4.2.2.1.1.1.1.Market size and forecast

4.2.2.1.1.2. Non-silver dressings

4.2.2.1.1.2.1.Market size and forecast

4.2.2.1.1.3. Collagen dressings

4.2.2.1.1.3.1.Market size and forecast

4.2.2.2. Exudate management

4.2.2.2.1. Market size and forecast

4.2.2.2.1.1. Hydrocolloid dressings

4.2.2.2.1.1.1.Market size and forecast

4.2.2.2.1.2. Foam dressings

4.2.2.2.1.2.1.Market size and forecast

4.2.2.2.1.3. Alginate dressings

4.2.2.2.1.3.1.Market size and forecast

4.2.2.2.1.4. Hydrogel dressings

4.2.2.2.1.4.1.Market size and forecast

4.2.2.3. Active wound care

4.2.2.3.1. Market size and forecast

4.2.2.3.1.1. Skin substitutes

4.2.2.3.1.1.1.Market size and forecast

4.2.2.3.1.2. Growth factors

4.2.2.3.1.2.1.Market size and forecast

4.2.2.4. Therapy device

4.2.2.4.1. Market size and forecast

4.2.2.4.1.1. Negative pressure wound therapy (NPWT)

4.2.2.4.1.1.1.Market size and forecast

4.2.2.4.1.2. Oxygen & hyperbaric oxygen equipment

4.2.2.4.1.2.1.Market size and forecast

4.2.2.4.1.3. Electromagnetic therapy devices

4.2.2.4.1.3.1.Market size and forecast

4.2.2.4.1.4. Others

4.2.2.4.1.4.1.Market size and forecast

4.3. SURGICAL WOUND CARE

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast

4.3.2.1. Sutures & staples

4.3.2.1.1. Market size and forecast

4.3.2.2. Tissue adhesives, sealants, & glues

4.3.2.2.1. Market size and forecast

4.3.2.2.1.1. Fibrin-based sealants

4.3.2.2.1.1.1.Market size and forecast

4.3.2.2.1.2. Collagen-based sealants

4.3.2.2.1.2.1.Market size and forecast

4.3.2.2.1.3. Synthetic adhesives/glues

4.3.2.2.1.3.1.Market size and forecast

4.3.2.3. Anti-infective dressing

4.3.2.3.1. Market size and forecast

4.4. TRADITIONAL/BASIC WOUND CARE

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast

4.4.2.1. Medical tapes

4.4.2.1.1. Market size and forecast

4.4.2.2. Dressings

4.4.2.2.1. Market size and forecast

4.4.2.3. Cleansing agents

4.4.2.3.1. Market size and forecast

Chapter: 5: PHILIPPINES WOUND CARE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CHRONIC WOUNDS

5.2.1. Market size and forecast

5.2.1.1. Pressure ulcers

5.2.1.1.1. Market size and forecast

5.2.1.2. Diabetic foot ulcers

5.2.1.2.1. Market size and forecast

5.2.1.3. Venous leg ulcers

5.2.1.3.1. Market size and forecast

5.2.1.4. Arterial ulcers

5.2.1.4.1. Market size and forecast

5.3. ACUTE WOUNDS

5.3.1. Market size and forecast

5.3.1.1. Burns & trauma

5.3.1.1.1. Market size and forecast

5.3.1.2. Surgical wounds

5.3.1.2.1. Market size and forecast

Chapter: 6: PHILIPPINES WOUND CARE MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. COMMUNITY HEALTH SERVICE CENTERS

6.3.1. Market size and forecast

Chapter: 7: COMPANY PROFILES

7.1. 3M COMPANY

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. B. BRAUN MELSUNGEN AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. CARDINAL HEALTH, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance

7.4. COLOPLAST A/S

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. CONVATEC GROUP PLC

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. MEDTRONIC PLC. (COVIDIEN LTD.)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. MUNDIPHARMA INTERNATIONAL LIMITED

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio

7.8. SMITH & NEPHEW PLC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance

7.9. SVENSKA CELLULOSA AKTIEBOLAGET (BSN MEDICAL GMBH)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Product portfolio
7.9.4. Business performance

7.10. URGO GROUP (URGO MEDICAL)

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio